Hims & Hers shares drop 6% after FDA warning on semaglutide marketing claims
Hims(US:HIMS) Invezz·2025-09-17 01:45Hims & Hers Health Inc. (NYSE: HIMS) saw its stock fall 6% on Tuesday following the release of a warning letter from the US Food and Drug Administration (FDA) concerning marketing claims related to it... ...